Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers. (2022)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bja.2021.10.054
PubMed Identifier: 34998508
Publication URI: http://europepmc.org/abstract/MED/34998508
Type: Journal Article/Review
Volume: 128
Parent Publication: British journal of anaesthesia
Issue: 3
ISSN: 0007-0912